Skip to main content

User account menu

Show — User account menu Hide — User account menu
  • Log in
Home
Amarin

Breadcrumb

  1. Home
  2. News
  3. Amarin Marks Key Milestone for VASCEPA®/VAZKEPA® (Icosapent Ethyl) -- Publication of Post Hoc Analysis of REDUCE-IT in Journal of the American Heart Association Reports Benefit on Top of Cholesterol Lowering
Submitted by amarin on Thu, 02/27/2025 - 14:00
Home
News
Amarin Marks Key Milestone for VASCEPA®/VAZKEPA® (Icosapent Ethyl) -- Publicati…
ID Reference
24456

Tags

  • General Releases
Page Tags
Global
News / Press Release
News & Media
News title
Amarin Marks Key Milestone for VASCEPA®/VAZKEPA® (Icosapent Ethyl) -- Publication of Post Hoc Analysis of REDUCE-IT in Journal of the American Heart Association Reports Benefit on Top of Cholesterol Lowering

Search

API search

Title (indexed field):
Title (indexed field):
Title (indexed field):
Title (indexed field):
Title (indexed field): t1

Footer menu

Show — Footer menu Hide — Footer menu
  • Contact
Powered by Drupal